Your browser doesn't support javascript.
loading
Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature.
Kim, Myung-Ho; Kim, Mi-Young; Salloum, Shadi; Qian, Tongqi; Wong, Lai Ping; Xu, Min; Lee, Yoojin; Shroff, Stuti G; Sadreyev, Ruslan I; Corey, Kathleen E; Baumert, Thomas F; Hoshida, Yujin; Chung, Raymond T.
Afiliação
  • Kim MH; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Kim MY; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Salloum S; Department of Gastroenterology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea.
  • Qian T; Department of Gastroenterology, Chaum Life Center, CHA University School of Medicine, Seoul, South Korea.
  • Wong LP; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Xu M; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Lee Y; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Shroff SG; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
  • Sadreyev RI; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Corey KE; Liver Center, Gastrointestinal Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Baumert TF; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Hoshida Y; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Chung RT; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Hepatol Commun ; 6(9): 2581-2593, 2022 09.
Article em En | MEDLINE | ID: mdl-35712812
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Inibidores de Hidroximetilglutaril-CoA Redutases / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hepatol Commun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Carcinoma Hepatocelular / Inibidores de Hidroximetilglutaril-CoA Redutases / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Hepatol Commun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos